Lathrop Gage LLP
Mr. DeConti has more than 30 years of experience practicing intellectual property law and specializes in intellectual property strategy in biotechnology, pharmaceuticals, and chemistry. His technical specialties include drugs, proteins, peptides and antibodies (monoclonal antibodies), nucleic acids (siRNA), small organic molecules, drug discovery technology, recombinant DNA, and genomics.
Mr. DeConti works interactively with clients to build strong patent portfolios that protect the commercialization of biological, pharmaceutical, and chemical products and related technologies. He has extensive experience in IP due diligence, patentability, validity and infringement opinions, licensing, and the preparation and prosecution of patents. He brings this experience to each client relationship to help create and implement optimal strategies for creating strong patent portfolios and securing worldwide protection of a client’s intellectual property. Mr. DeConti currently serves as the Chair of the firm’s Intellectual Property Division.
Prior to joining Lathrop & Gage, Mr. DeConti spent 20 years with Lahive & Cockfield, where he was a partner and served as Chair of the firm’s Executive Committee from 2001-2007.
His notable experience includes: